Visteon Corp's stock experienced a notable pre-market uptick, rising 4.0% after JPMorgan upgraded the automotive electronics supplier from Neutral to Overweight and increased its price target sharply from $108 to $165.
Analyst Rajat Gupta cited a firm foundation for sustainable growth, pointing to a pipeline of recent contract wins and the expected commercial ramp of Visteon's next-generation SmartCore high-performance central (HPC) platform. Gupta said these factors support an outlook for high single-digit revenue expansion across the next three to five years.
Under JPMorgan's updated financial assumptions, Visteon could reach roughly $5 billion or more in annual revenue and exceed $700 million in EBITDA by 2029. The bank's model translates to approximately 10% compound annual growth in revenue and about 15% compound annual growth in EBITDA from 2026 base levels.
Market participants also noted the timing of the upgrade relative to Visteon's upcoming Investor Day in New York City on June 25, an event scheduled just three days away. Chief executive Sachin Lawande and chief financial officer Jerome Rouquet are expected to present the company's strategic priorities, growth drivers and financial targets, an occasion that may have encouraged JPMorgan to publish its revised view prior to the meeting.
The broader market backdrop provided further support for the move. The Nasdaq advanced 1.9% while the S&P 500 rose 1.1% as equities sought to regain footing following a sharp selloff the prior week after the Federal Reserve took a more hawkish tone. Under new Federal Reserve Chair Kevin Warsh, the central bank held interest rates steady but signaled that nearly half of FOMC members expect at least one rate hike before year-end - a stance that had pressured growth-oriented stocks, including Visteon.
Those combined elements - the magnitude of JPMorgan's price-target revision, the imminent Investor Day and a recovering market - pushed Visteon's shares to $118.30 in pre-market trade, notably higher than the previous close of $113.81 and drawing the stock closer to its 52-week peak of $129.10.
Investors will likely look to the Investor Day for additional detail on the company's roadmap and financial targets, while monitoring whether the revenue and EBITDA trajectories embedded in JPMorgan's model align with the company's own guidance and subsequent execution.